California Proposes New CBD Regulations & Registration Requirements
FDA Issues New Warning Letters For Delta-8 and CBD Products
Dr. Robert Califf Confirmed to Head FDA
Introduction of Senate Cannabis Descheduling Bill Anticipated in April 2022
FDA Releases Plan to Obtain Data Regarding Cannabis-Derived Product Usage & Safety

The Role of State AGs in Cannabis Policy and Regulation: A Conversation with Austin Bernstein
